5 results on '"Hyungu Kang"'
Search Results
2. Hybridization-based aptamer labeling using complementary oligonucleotide platform for PET and optical imaging
- Author
-
Ju Ri Chae, Mijin Yun, Hyungu Kang, Jong Hoon Lim, Jung Hwan Lee, Won Gil Cho, Won Jun Kang, Jun Young Park, Tae Sup Lee, In Ho Song, and Ye Lim Cho
- Subjects
0301 basic medicine ,Fluorine Radioisotopes ,Aptamer ,Oligonucleotides ,Biophysics ,Mice, Nude ,Bioengineering ,CHO Cells ,Biology ,Biomaterials ,03 medical and health sciences ,Cricetulus ,0302 clinical medicine ,Optical imaging ,Cell Line, Tumor ,Neoplasms ,Animals ,Fluorescent Dyes ,Base Sequence ,Oligonucleotide ,Optical Imaging ,Nucleic Acid Hybridization ,Aptamers, Nucleotide ,Combinatorial chemistry ,Fluorescence ,Rats ,030104 developmental biology ,Complementary sequences ,Mechanics of Materials ,Positron-Emission Tomography ,030220 oncology & carcinogenesis ,Ceramics and Composites ,Nucleic acid ,Female ,Molecular imaging - Abstract
Aptamers are promising next-generation ligands used in molecular imaging and theragnosis. Aptamers are synthetic nucleic acids that can be held together with complementary sequences by base-pair hybridization. In this study, the complementary oligonucleotide (cODN) hybridization-based aptamer conjugation platform was developed to use aptamers as the molecular imaging agent. The cODN was pre-labeled with fluorescent dye or radioisotope and hybridized with a matched sequence containing aptamers in aqueous conditions. The cODN platform-hybridized aptamers exhibited good serum stability and specific binding affinity towards target cancer cells both in vitro and in vivo. These results suggest that the newly designed aptamer conjugation platform offers great potential for the versatile application of aptamers as molecular imaging agents.
- Published
- 2016
- Full Text
- View/download PDF
3. In vivo real-time bioimaging of hyaluronic acid derivatives using quantum dots
- Author
-
Sei Kwang Hahn, Ki Su Kim, Hyungu Kang, Moon Hyang Park, Ge Jiang, Byung Soo Kim, Jiseok Kim, and Sungjee Kim
- Subjects
Molecular Sequence Data ,Biophysics ,Mice, Nude ,Conjugated system ,Biochemistry ,Fluorescence spectroscopy ,Biomaterials ,Gel permeation chromatography ,Mice ,chemistry.chemical_compound ,Hyaluronic acid ,Animals ,Hyaluronic Acid ,Carbodiimide ,Organic Chemistry ,Chemical modification ,General Medicine ,Fluorescence ,Microscopy, Electron ,Carbohydrate Sequence ,chemistry ,Chromatography, Gel ,Potentiometry ,Quantum Theory ,Adipic acid dihydrazide ,Nuclear chemistry - Abstract
The effect of chemical modification of hyaluronic acid (HA) on its distribution throughout the body was successfully visualized in nude mice through real-time bioimaging using quantum dots (QDots). Adipic acid dihydrazide modified HA (HA-ADH) was synthesized and conjugated with QDots having carboxyl terminal ligands activated with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and N-hydroxysulfosuccinimide. The formation of HA-QDot conjugates could be confirmed by gel permeation chromatography, fluorometry, transmission electron microscopy, and ζ-size analysis. According to the real-time bioimaging of HA-QDot conjugates after subcutaneous injection to nude mice, the fluorescence of HA-QDot conjugates with a near infrared wavelength of 800 nm could be detected up to 2 months, whereas that with an emission wavelength of 655 nm disappeared almost completely within 5 days. The results can be ascribed to the fact that near-infrared light has a high penetration depth of about 5–6 cm in the body compared to that of about 7–10 mm for visible light. Thereby, using QDots with a near-infrared emission wavelength of 800 nm, the distribution of HA-QDot conjugates throughout the body was bioimaged in real-time after their tail-vein injection into nude mice. HA-QDot conjugates with 35 mol% ADH content maintaining enough binding sites for HA receptors were mainly accumulated in the liver, while those with 68 mol% ADH content losing much of HA characteristics were evenly distributed to the tissues in the body. The results are well matched with the fact that HA receptors are abundantly present in the liver with a high specificity to HA molecules. © 2008 Wiley Periodicals, Inc. Biopolymers 89: 1144–1153, 2008. This article was originally published online as an accepted preprint. The “Published Online” date corresponds to the preprint version. You can request a copy of the preprint by emailing the Biopolymers editorial office at biopolymers@wiley.com
- Published
- 2008
- Full Text
- View/download PDF
4. In vitro derby imaging of cancer biomarkers using quantum dots
- Author
-
Jung Hwan Lee, Sung Hwan Moon, Hyungu Kang, Won Jun Kang, Do Won Hwang, Dong Soo Lee, Mee Hyang Ko, Hae Young Ko, and Soonhag Kim
- Subjects
Fluorescence-lifetime imaging microscopy ,Aptamer ,Fluorescence ,Biomaterials ,Imaging, Three-Dimensional ,Cell Line, Tumor ,Quantum Dots ,Biomarkers, Tumor ,Humans ,General Materials Science ,Microscopy, Confocal ,Chemistry ,technology, industry, and agriculture ,RNA-Binding Proteins ,General Chemistry ,Aptamers, Nucleotide ,equipment and supplies ,Integrin alphaVbeta3 ,Phosphoproteins ,Molecular biology ,Small molecule ,Oligodeoxyribonucleotides ,Quantum dot ,Cancer cell ,Biophysics ,Cancer biomarkers ,Nucleolin ,Oligopeptides ,Biotechnology - Abstract
Semiconductor quantum dots (QDs), which have broad absorption with narrow emission spectra, are useful for multiplex imaging. Here, fluorescence derby imaging using dual color QDs conjugated by the AS1411 aptamer (targeting nucleolin) and the arginine-glycine-aspartic acid (targeting the integrin alpha(v)beta(3)) in cancer cells is reported. Simultaneous fluorescence imaging of cellular distribution of nucleolin and integrin alpha(v)beta(3) using QDs enables easy monitoring of separate targets in the cancer cells and the normal healthy cells. These results suggest the feasibility of a concurrent visualization of QD-based multiple cancer biomarkers using small molecules such as aptamer or peptide ligands.
- Published
- 2009
5. Bioimaging of Nucleolin Aptamer-Containing 5-(N-benzylcarboxyamide)-2'-deoxyuridine More Capable of Specific Binding to Targets in Cancer Cells.
- Author
-
Kyue Yim Lee, Hyungu Kang, Sung Ho Ryu, Dong Soo Lee, Jung Hwan Lee, and Soonhag Kim
- Subjects
- *
CANCER cells , *NUCLEOTIDES , *PROTEINS , *FLUORESCENCE , *CHEMICAL modification of proteins - Abstract
Chemically modified nucleotides have been developed and applied into SELEX procedure to find a novel type of aptamers to fit with targets of interest. In this study, we directly performed chemical modification of 5-(N-benzylcarboxyamide)-2′-deoxyuridine (called 5-BzdU) in the AS1411 aptamer, which binds to the nucleolin protein expressed in cancer cells. Forty-seven compounds of AS1411-containing Cy3-labeled 5-BzdU (called Cy3-(5-BzdU)-modified-AS1411) were synthesized by randomly substituting thymidines one to twelve in AS1411 with Cy3-labeled 5-BzdU. Both statistically quantified fluorescence measurements and confocal imaging analysis demonstrated at least three potential compounds of interest: number 12, 29 and 41 that significantly increased the targeting affinity to cancer cells but no significant activity from normal healthy cells. These results suggest that the position and number of substituents in AS1411 are critical parameters to improve the aptamer function. In this study, we demonstrated that chemical modification of the existing aptamers enhanced the binding and targeting affinity to targets of interest without additional SELEX procedures. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.